Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis

Annals of Saudi Medicine

Volumn 24, Issue 4, 2004, Pages 284-287

  Khalid, Mohammed ^a   Saleemi, Sarfraz ^a   Zeitouni, Mohammed ^a   Al Dammas, Saleh ^a   Khaliq, Muhammad Rehan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Morbidity; Mortality; Non cystic fibrosis bronchiectasis; Obstructive airway disease; Pulmonary function tests

Indexed keywords

SALBUTAMOL;

ADOLESCENT; ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTERIAL GAS; ARTICLE; ASPERGILLUS; BACTERIAL COLONIZATION; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; HYPERCAPNIA; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORAXELLA CATARRHALIS; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY;

EID: 4344685191     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.284     Document Type: Article

References (26)

1. Weinberger, Steven E, Fettner AG. Disease in Disguise: Bronchiectasis. Harvard Health. 1996.
2. Kolbe J, Welss U. Bronchiectasis: a neglected cause of respiratory morbidity and mortality. Respirology. 1996;1(4): 221-225.
3. Holmes AH, Trotman-Dickenson B, Edwards A, Petot, Luzzi GA. Bronchiectasis in HIV disease. QJM. 1992;85: 875-882.
4. Shiekh S, Madiraju K, Steiner P, Rao M. Bronchiectasis in Pediatric AIDS. Chest. 1997;112: 1202-1207.
5. MCGuinness G, Naidich P, Garay S, Leitman BS, McCauley DI. AIDS Associated Bronchiectasis: CT features. J Comput Assist Tomogr. 1993;17:260-266.
6. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiectasis: the influence of pseudomonas aeruginosa. Eur Respir J. 1996; 9(8): 1601-1604.
7. Hernandez C, Abren J, Jimenez A, Fernandez K, Martin C. Pulmonary function and quality of life in relation to bronchial colonization in adults with bonchiectasis not caused by cystic fibrosis. Med Clin (Barc). 2002;9:118.
8. Wilson CB, Jones PW, O Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of Sputum Bacteriology on Quality of Life of Patients with Bronchiectasis. Eur Respir J. 1997;10(8):1754-1760.
9. www.thoracic.org
10. Monteverde A, Gonzales A, Fernandez A et al
11. Bronchiectasia in HIV-positive patients. Medicina (B Aires). 1999; 59(1): 67-70.
12. Wells AV, Desai SR, Wetton C, Wilson R, Cole PJ. The Isolation of PseudomonasAeruginosa from Sputum in Idiopathic Brronchiectasis: An Association with Extensive Disease and Severe Airflow Obstruction. Am Rev Respir Dis. 1993; 147:645.
13. Angrill J, Augusti C, De Celis R, et al. Bacterial Colonozation in Patinets with Bronchiectasis, Microbiological Pattern and risk factors. Thorax. 2002;57:15-19.
14. Ho PL, Chan KN, Ip MSM, et al. The Effect of Pseudomonas Aeruginosa Infection in Clinical Parameters in Steady State Bronchiectasis. Chest. 1998; 114: 1594-1598.
15. Gaza M, Bentley AM, Humbert M, et al. Increases in CD4+ T Lymphocytes, Macrophages, Neutrophils and Interleukin 8 Positive Cells in Airways of Patients with Bronchiectasis. Thorax. 1998; 53: 685-691.
16. Cochrane M, Webber BA, Clarke SW. Effects of Sputum on Pulmonary Function. BMJ. 1977; 2: 1181-1183.
17. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, Pathophysiologic and Microbiologic Characterization of Bronchiectasis in An Aging Cohort. Chest. 1995;108:955-961.
18. Rayner CFJ, Tillotson G, Cole PJ, Wilson R. Efficacy and Safety of Long Term Ciprofloxacin in the Management of Severe Bronchiectasis. J Antimicrob Chemother. 1994; 34: 149-156.
19. Barker AF, Couch L, Fiel SB, et al. Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas Aeruginosa Density in Bronchiectasis. Am J Respir Crit Care Med. 2000; 162: 481-485.
20. Lin HC, Cheng HF, Wang CH, Lin CY, Yu CT, Kho HP. Inhaled Gentamycin Reduces Airway Neutrophil Activity and Mucus Hypersecretion in Bronchiectasis. Am J Respir Crit Care Med. 1997; 155: 2024-2029.
21. Bahous J, Cartier A, Pineau L, et al. Pulmonary Function Tests and Airway Responsiveness to Metacholine in Chronic Bronchiectasis of Adult. Bull Europ Physiopathol Respir. 1984; 20: 375-380.
22. Nogrady SG, Evans WV, Davies BM. Reversibility of Airways Obstruction in Bronchiectasis. Thorax. 1977; 33: 668-672.
23. Franco F, Sheikh A, Greenstone M. Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev. 2003; (3): CD003572.
24. Tsang KW, Lam WK, Sun J, Ooi GG. Regression of Bilateral Bronchiectasis with Inhaled Steroid Treatment. Respirology. 2002; 7(1): 77-84.
25. Tsang KWT, Ho PL, Lam WK, et al. Inhaled Fluticasone Reduces Sputum Inflammatory Indices in Severe Bronchiectasis. Am J Respir Crit Care Med. 1998; 158: 723-727.
26. Jones A, Rowe BH. Bronchopulmonary Hygiene Physical Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease: A Systemic Review. Heart Lung. 2000; 29: 125-135.